Company
Coave Therapeutics
Redefining targeted gene therapy
Also known as Coave Therapeutics SA
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Paris, France
- Legal name
- Coave Therapeutics SA
Claim, correct or request removal
Record updated 28 September 2026
About
Starting with ophthalmology, Coave Therapeutics is redefining targeted gene therapy by solving its most critical challenge: delivery. Through its proprietary ALIGATER™ platform, the Company has pioneered the world’s first ligand-conjugated AAVs, enabling Precision Vectors that are highly tissue specific, precisely delivered and safer than traditional approaches.
Products
- Other
- ALIGATER
- Other
- CoTx-101
Loading relationship preview